Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
Drug Addiction Special
Program
Track
      
spacer  

A Treatable Disease

A highlight of the upcoming American Psychiatric Association (APA) Annual Meeting will be a special research-based program track on drug abuse and addiction. The result of a unique collaboration of the National Institute on Drug Abuse (NIDA) and the APA, the program track is open to all meeting registrants (no prior registration is needed). Sessions will be held Monday, June 1 through Thursday, June 4. A program book will be available at registration. Below are listed some of the exciting events scheduled. See you there!

Monday, June 1
Behavioral Approaches to the Treatment of Drug Dependence
Charles R. Schuster, Ph.D.

Substance Abuse and the Reward Systems in the Brain
Floyd E. Bloom, M.D.

Research Advances in Psychiatry: An Update for the Clinician
Alan I. Leshner, Ph.D.

Risk and Vulnerability to Drug Abuse
Ralph E. Tarter, Ph.D.
Kathleen R. Merikangas, Ph.D.
Denise Kandel, Ph.D.
Sheppard G. Kellam, M.D.

NIH Grantsmanship Workshop: Do's and Don'ts in Writing Your First NIH Grant
Teresa Levitin, Ph.D.
David Shore, M.D.

Tuesday, June 2
How to Help Your Patients Stop Smoking
John R. Hughes, M.D.
Susan J. Fiester, M.D.

The Effects of Perinatal Exposure to Cocaine
Frances R. Levin, M.D.
Deborah Frank, M.D.
Linda Mayes, M.D.
Loretta P. Finnegan, M.D.

Dual Diagnosis: Cases and Discussion
Sheldon I. Miller, M.D.

Choosing the Right Treatment for Opiate Dependence
Jerome H. Jaffe, M.D.

Spectrum of Substance Abuse: Research from the Brain to the Streets
Carol L. M. Caton, Ph.D.
David A. Gorelick, M.D.

Women's Issues in Drug Abuse: Violence, Trauma, Victimization
Linda Teplin, Ph.D.
Sheila B. Blume, M.D.

The Surprising Efficacy of Treatments for Addictive Disorders
Charles P. O'Brien, M.D., Ph.D.

Conundrums of Comorbidity
Kathleen T. Brady, M.D.
David M. McDowell, M.D.
Frances R. Levin, M.D.
Andrew L. Shaner, M.D.
John S. Cacciola, Ph.D.
Edward V. Nunes, M.D.

Psychosocial Interventions for Drug Abuse
Stephen T. Higgins, Ph.D.
Thomas McLellan, Ph.D.
Marsha M. Linehan, Ph.D.
Timothy J. O'Farrell, Ph.D.
Bruce J. Rousanville, M.D.

Substance Abuse in Youth - A British Perspective: Trainspotting
Timothy P. Condon, Ph.D.

Wednesday, June 3
Substance Use Disorders and HIV Infection in 1998: Where Are We With Prevention and Treatment?
Stephen J. Ferrando, M.D.

Effective Engagement of the Substance Abuser in Office Practice
Marc Galanter, M.D.

Prevention of Substance Abuse Risk for Families at Risk
Ian E. Alger, M.D.
Lawrence J. Hatterer, M.D.

Alcohol, Tobacco, and Other Drugs (ATOD)-TV and Community Attitudes Regarding Drug Abuse
Timothy P. Condon, Ph.D.

Who Will Pay for the Treatment of Substance Abuse?
Sheldon I. Miller, M.D.
Jerome H. Jaffe, M.D.
William H. Goldman, M.D.

Cocaine and the Addicted Brain
Nora D. Volkow, M.D.

Medications Development for Substance Dependence
Thomas R. Kosten, M.D.
Charles P. O'Brien, M.D.
Eric C. Strain, M.D.
Marian W. Fischman, Ph.D.
Frank J. Vocci, Ph.D.
Herbert D. Kleber, M.D.

Detection and Treatment of Stimulant Abuse
Jeffery N. Wilkins, M.D.
Douglas M. Ziedonis, M.D.
David A. Gorelick, M.D.
Richard N. Rosenthal, M.D.
Steven L. Batki, M.D.

Thursday, June 4
Matching Drug-Addicted Patients to Services
David R. Gastfriend, M.D.
Andrea Barthwell, M.D.

Review of Psychiatry: Addictions
Elinore F. McCance-Katz, M.D.
Robert P. Cabaj, M.D.
H. Westley Clark, M.D.
Myroslava K. Romach, M.D.
Susan M. Stine, M.D.
Douglas M. Ziedonis, M.D.

Comorbid Depression, Personality Disorder and Substance Misuse
Stewart Gabel, M.D.

Treating Nicotine Dependence in Psychiatric Patients
Michael G. Goldstein, M.D.
Alexander H. Glassman, M.D.
Raymond S. Niaura, Ph.D.
Douglas M. Ziedonis, M.D.
John R. Hughes, M.D.

Results of the NIDA Collaborative Cocaine Treatment Study
Lynne Siqueland, Ph.D.
Paul Crits-Cristoph, Ph.D.
Michael E. Thase, M.D.
Arlene F. Frank, Ph.D.
Roger D. Weiss, M.D.

New Approaches for Opiate Detoxification
John Strang, M.D.
Thomas R. Kosten, M.D.
Herbert D. Kleber, M.D.
Janet Knoefal, Ph.D.
Bruce J. Rounsaville, M.D.
Charles E. Riordan, M.D.

New Treatments for Heroin Addiction
Laurence M. Westreich, M.D.
Paul P. Casadonte, M.D.
Paul J. Fudala, Ph.D.
Duncan McGonagle, R.N.
Lance L. Gooberman, M.D.


A Collaboration of
National Institute on Drug Abuse
National Institutes of Health
and the American Psychiatric Association

American Psychiatric Association
151st Annual Meeting
Toronto, Canada
May 30 - June 4, 1998

CME sponsored by American Psychiatric Association



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal